| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;82:530-536
© 2006 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, University Clinic Gasthuisberg, Leuven, Belgium
b Department of Cardiology, University Clinic Gasthuisberg, Leuven, Belgium
Accepted for publication March 28, 2006.
* Address correspondence to Prof Dr Flameng, Cardiac Surgery, University Clinic Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium (Email: willem.flameng{at}med.kuleuven.be).
BACKGROUND: Previous studies have shown that prosthesis–patient mismatch (PPM) results in higher early and late mortality after bioprosthetic aortic valve replacement. Careful selection of stented bioprostheses was recommended to avoid inadequate effective orifice area. We studied the incidence of PPM and its potential effects on clinical outcome in patients undergoing aortic valve replacement using the Carpentier-Edwards Perimount bioprosthesis.
METHODS: Independent predictors of early and late mortality and hospital readmission for cardiac reasons were defined in 506 patients (mean age, 73 years; range, 57 to 87 years) by multivariate analysis. Mean follow-up was 6.1 ± 4.8 years; maximum follow-up was 18.6 years.
RESULTS: The incidence of severe PPM (effective orifice area index < 0.65 cm2/m2) was 0.2% and of moderate PPM (effective orifice area index > 0.65 and < 0.85) was 20%. Multivariate analysis revealed that moderate PPM was not an independent predictor of early mortality, late mortality, or hospital readmission for cardiac reasons. Reduction of septal hypertrophy was similar in patients with and without moderate PPM.
CONCLUSIONS: The incidence of severe PPM is virtually nonexistent after aortic valve replacement using the Carpentier-Edwards Perimount valve. Moderate PPM is found in 20% of cases and is clinically irrelevant in this population.
This article has been cited by other articles:
|
|
 |
|
  R. M. Suri, H. I. Michelena, H. M. Burkhart, K. L. Greason, R. C. Daly, J. A. Dearani, S. J. Park, L. D. Joyce, J. M. Stulak, T. M. Sundt III, et al. A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: Should hemodynamic performance influence device selection? J. Thorac. Cardiovasc. Surg., December 1, 2012; 144(6): 1387 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Head, M. M. Mokhles, R. L. J. Osnabrugge, P. Pibarot, M. J. Mack, J. J. M. Takkenberg, A. J. J. C. Bogers, and A. P. Kappetein The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years Eur. Heart J., June 2, 2012; 33(12): 1518 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. LaPar, G. Ailawadi, C. M. Bhamidipati, G. Stukenborg, I. K. Crosby, J. A. Kern, and I. L. Kron Small Prosthesis Size in Aortic Valve Replacement Does Not Affect Mortality Ann. Thorac. Surg., September 1, 2011; 92(3): 880 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Brown, H. V. Schaff, R. M. Suri, Z. Li, T. M. Sundt, J. A. Dearani, and M. Enriquez-Sarano Regression in left ventricular mass after aortic valve replacement for chronic aortic regurgitation is unrelated to prosthetic valve size J. Thorac. Cardiovasc. Surg., August 1, 2011; 142(2): e5 - e9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Dalmau, J. M. Gonzalez-Santos, J. A. Blazquez, J. A. Sastre, J. Lopez-Rodriguez, M. Bueno, M. Castano, and A. Arribas Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: five-year results of a prospectively randomized study Eur J Cardiothorac Surg, June 1, 2011; 39(6): 844 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bleiziffer, A. Ali, I. M. Hettich, D. Akdere, R. P. Laubender, D. Ruzicka, J. Boehm, R. Lange, and W. Eichinger Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement Heart, June 1, 2010; 96(11): 865 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Flameng, M. C. Herregods, M. Vercalsteren, P. Herijgers, K. Bogaerts, and B. Meuris Prosthesis-Patient Mismatch Predicts Structural Valve Degeneration in Bioprosthetic Heart Valves Circulation, May 18, 2010; 121(19): 2123 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Suri, K. J. Zehr, T. M. Sundt III, J. A. Dearani, R. C. Daly, J. K. Oh, and H. V. Schaff Left Ventricular Mass Regression After Porcine Versus Bovine Aortic Valve Replacement: A Randomized Comparison Ann. Thorac. Surg., October 1, 2009; 88(4): 1232 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Price, H. Lapierre, L. Ressler, B.-K. Lam, T. G. Mesana, and M. Ruel Prosthesis-patient mismatch is less frequent and more clinically indolent in patients operated for aortic insufficiency J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 639 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Urso, R. Sadaba, and G. Aldamiz-Echevarria Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact CardioVasc Thorac Surg, September 1, 2009; 9(3): 510 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Moon, J. S. Lawton, N. Moazami, N. A. Munfakh, M. K. Pasque, and R. J. Damiano Jr. POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age undergoing bioprosthetic aortic valve replacement. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 278 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Bleiziffer, W B Eichinger, I Hettich, D Ruzicka, M Wottke, R Bauernschmitt, and R Lange Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement Heart, May 1, 2008; 94(5): 637 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al. Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Totaro and V. Argano Patient prosthesis mismatch after mitral valve replacement: Myth or reality? J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 697 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garcia Fuster, V. Estevez, I. Rodriguez, S. Canovas, O. Gil, F. Hornero, and J. Martinez-Leon Prosthesis-patient mismatch with latest generation supra-annular prostheses. The beginning of the end? Interact CardioVasc Thorac Surg, August 1, 2007; 6(4): 462 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dalmau, J. Maria Gonzalez-Santos, J. Lopez-Rodriguez, M. Bueno, A. Arribas, and F. Nieto One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study Interact CardioVasc Thorac Surg, June 1, 2007; 6(3): 345 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bleiziffer, W. B Eichinger, I. Hettich, R. Guenzinger, D. Ruzicka, R. Bauernschmitt, and R. Lange Prediction of valve prosthesis-patient mismatch prior to aortic valve replacement: which is the best method? Heart, May 1, 2007; 93(5): 615 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gerosa, V. Tarzia, G. Rizzoli, and T. Bottio Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 847 - 849. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
